Sclerostin binding agents

Details for Australian Patent Application No. 2006242431 (hide)

Owner UCB Pharma S.A. Amgen, Inc.

Inventors Shen, Wenyan; Paszty, Christopher; Henry, Alistair James; Graham, Kevin; Popplewell, Andy; Hoffmann, Kelly Sue; Winters, Aaron George; Lawson, Alastair; Lu, Hsieng Sen; Robinson, Martyn Kim; Latham, John; Winkler, David

Agent Davies Collison Cave

Pub. Number AU-A-2006242431

PCT Pub. Number WO2006/119107

Priority 11/411,003 25.04.06 US; 60/677,583 03.05.05 US; 60/782,244 13.03.06 US; 60/792,645 17.04.06 US; 60/776,847 24.02.06 US

Filing date 28 April 2006

Wipo publication date 9 November 2006

International Classifications

C07K 14/51 (2006.01) Peptides having more than 20 amino acids

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

Event Publications

22 November 2007 PCT application entered the National Phase

  PCT publication WO2006/119107 Priority application(s): WO2006/119107

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006242440-Gantry tower spraying system with cartridge/receptacle assembly

2006242425-Heavy-duty vehicle axle/suspension system